한글목차

생분해성 지혈제 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 9억 7,000만 달러에서 2026년에는 10억 8,000만 달러로, CAGR 11.3%로 성장이 전망되고 있습니다. 과거 성장의 원인은 기존 비흡수성 지혈제에 대한 의존도, 수술 건수 증가, 병원 인프라 확충, 출혈 관리에 대한 인식 개선, 기초적인 상처 관리 기술 도입 등이 원인으로 추정됩니다.

생분해성 지혈제 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 16억 3,000만 달러에 달하며, CAGR은 10.8%에 달할 전망입니다. 예측 기간 중의 성장에는 고분자 및 생체 재료 과학의 발전, 최소 침습 수술 증가, 외상 및 응급 사례 증가, 생분해성 장치의 규제 승인 확대, 외래수술센터(ASC)의 확장 등이 영향을 미칠 것으로 예측됩니다. 예측 기간 중 주요 동향으로는 흡수성 지혈제 제품 채택 증가, 생체 적합성 및 생체흡수성 재료에 대한 선호도 증가, 최소 침습 수술 및 복강경 수술에서의 사용 확대, 외상 및 응급의료에서의 첨단 지혈제 보급, 즉시 사용 가능한 간편 지혈제에 대한 수요 증가 등을 들 수 있습니다.

수술 건수 증가는 향후 수년간 생분해성 지혈제 시장의 성장을 촉진할 것으로 예측됩니다. 외과수술은 의료 전문가가 전문 기구를 사용하여 건강상의 이유로 신체 일부를 치료, 수리, 절제하는 의료 시술입니다. 수술 건수 증가는 주로 건강 문제를 관리하고 환자 결과를 개선하기 위해 외과적 개입이 필요한 만성질환의 유병률 증가에 기인합니다. 생분해성 지혈제는 사용 후 체내에서 자연 분해되므로 제거할 필요가 없어 수술 후 합병증 위험을 줄일 수 있다는 장점이 있습니다. 예를 들어 미국 의료기기 제조업체인 Intuitive Surgical Inc.에 따르면 2025년 1월 기준 2024년 OUS(일반외과) 수술 건수는 2023년 약 42% 증가에 이어 2024년에도 약 35% 증가할 것으로 예상했습니다. 두 해 모두 추가 수술 건수 중 가장 큰 비중을 차지한 것은 대장 수술이었습니다. 그 결과, 수술 건수 증가는 생분해성 지혈제 시장의 성장을 가속하고 있습니다.

생분해성 지혈제 시장의 주요 기업은 식물 유래 셀룰로오스 매트릭스 등 혁신적인 솔루션 개발에 주력하여 신속한 지혈과 출혈량 감소를 위해 노력하고 있습니다. 식물 유래 셀룰로오스 매트릭스는 식물 섬유에서 추출한 생분해성 물질로, 자연적 지지 구조를 제공하고 체내에 안전하게 흡수되어 의료용으로 적합합니다. 2024년 4월, 미국 의료기기 제조업체 생명과학 플러스(Life Science Plus)는 100% 식물성 셀룰로오스로 만든 독자적인 지혈 드레싱 '도너실(Donor Seal)'을 발표했습니다. 혈액과 접촉하면 겔 형태로 변해 효과적으로 지혈하는 동시에 완전 생분해성, 흡수성, 무독성, 중성 pH 특성을 가지고 있으며, 항응고제를 복용 중인 환자에게도 안전합니다. 또한 촉촉하고 부드러운 환경을 형성하여 자연적 조직 치유를 촉진합니다. 이 드레싱은 상처가 다시 벌어지거나 달라붙지 않고 쉽게 제거할 수 있으며, 기증자 부위의 편안함을 높이고 회복을 촉진합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A biodegradable hemostat is a medical device designed to assist in blood clotting and control bleeding by triggering or speeding up the body's natural coagulation process. It is made to be safely absorbed and broken down by the body over time, eliminating the need for surgical removal. These hemostats are developed with biocompatibility to reduce the risk of adverse reactions while promoting wound healing.

The main types of biodegradable hemostats include natural polymer-based, synthetic polymer-based, composite, cellulose-based, and gelatin-based hemostats. Natural polymer-based hemostats are derived from naturally sourced polymers that aid in stopping bleeding by supporting blood clot formation during medical procedures. They come in various forms such as powders, granules, liquids, foams, and films or sheets, and are used in surgeries, trauma care, dental procedures, laparoscopic surgeries, and more. These products are distributed through direct sales, distributors, e-commerce platforms, pharmaceutical retailers, and healthcare supply companies, serving end users like hospitals, ambulatory surgical centers, clinics, research labs, and others.

Tariffs are impacting the biodegradable hemostat market by increasing costs for imported raw materials such as natural polymers, synthetic biomaterials, and specialized manufacturing inputs. Product segments like composite and synthetic polymer-based hemostats are most affected, particularly in Asia-Pacific and Europe where cross-border sourcing is common. These cost pressures have influenced pricing and supply chain strategies for manufacturers. However, tariffs have also encouraged local sourcing, domestic production, and innovation in alternative biodegradable materials, supporting long-term market growth.

The biodegradable hemostat market research report is one of a series of new reports from The Business Research Company that provides biodegradable hemostat market statistics, including biodegradable hemostat industry global market size, regional shares, competitors with a biodegradable hemostat market share, detailed biodegradable hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable hemostat industry. This biodegradable hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biodegradable hemostat market size has grown rapidly in recent years. It will grow from $0.97 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to reliance on conventional non-absorbable hemostats, growing surgical procedure volumes, increasing hospital infrastructure, rising awareness of blood loss management, adoption of basic wound care technologies.

The biodegradable hemostat market size is expected to see rapid growth in the next few years. It will grow to $1.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to advancements in polymer and biomaterial science, growth in minimally invasive surgical procedures, rising trauma and emergency cases, increasing regulatory approvals for biodegradable devices, expansion of ambulatory surgical centers. Major trends in the forecast period include rising adoption of absorbable hemostatic products, growing preference for biocompatible and bioabsorbable materials, increasing use in minimally invasive and laparoscopic surgeries, expansion of advanced hemostats in trauma and emergency care, higher demand for ready-to-use and easy-to-apply hemostats.

The rising number of surgical procedures is anticipated to drive the expansion of the biodegradable hemostat market in the coming years. Surgical procedures are medical interventions carried out by healthcare professionals using specialized instruments to treat, repair, or remove parts of the body for health-related reasons. The growth in surgical procedures is primarily due to the increasing prevalence of chronic conditions, which often require surgical intervention to manage health problems and enhance patient outcomes. Biodegradable hemostats provide a benefit in surgeries, as they naturally degrade within the body after use, eliminating the need for removal and reducing the risk of post-surgical complications. For example, in January 2025, according to Intuitive Surgical Inc., a US-based medical device company, OUS general surgery procedures rose by approximately 35% in 2024, following a growth of around 42% in 2023. Colorectal procedures contributed the largest share of additional volume in both years. Consequently, the increasing number of surgical procedures is fueling the growth of the biodegradable hemostat market.

Key players in the biodegradable hemostat market are concentrating on developing innovative solutions such as plant-based cellulose matrices to rapidly control bleeding and reduce blood loss. Plant-based cellulose matrices are biodegradable materials derived from plant fibers that provide a natural support structure and are safely absorbed by the body, making them suitable for medical use. In April 2024, LifeScience PLUS, a US-based medical device company, introduced DonorSeal, a distinctive hemostatic dressing made entirely from plant-sourced cellulose. DonorSeal forms a gel upon contact with blood, effectively stopping bleeding while being fully biodegradable, absorbable, non-toxic, and pH neutral, making it safe for patients on blood thinners. It also creates a moist, soothing environment that promotes natural tissue healing. The dressing can be removed easily without reopening wounds or sticking, enhancing comfort and speeding recovery at donor sites.

In March 2023, Medtrade Products Ltd, a UK-based biotechnology firm specializing in haemostasis, wound care, and trauma solutions, collaborated with Laubscher and Co AG to launch the CELOX PPH uterine haemostatic tamponade solution throughout Switzerland to tackle postpartum haemorrhage. Through this partnership, Medtrade aims to broaden access to its advanced haemostat technologies, enhance its presence in the Swiss market, and contribute to better maternal outcomes through rapid and effective bleeding management. Laubscher and Co AG is a Switzerland-based medical device company focusing on surgical and women's health solutions.

Major companies operating in the biodegradable hemostat market are Johnson And Johnson Services Inc, Medtronic Plc, Stryker Corporation, Baxter International Inc, Meril Life Sciences Pvt Ltd, Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc, Axio Biosolutions Pvt Ltd, Biom Up Inc

North America was the largest region in the biodegradable hemostat market in 2025. The regions covered in the biodegradable hemostat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodegradable hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biodegradable hemostat market consists of sales of polysaccharide hemostatic powders, flowable hemostatic agents, plant-based absorbable hemostats, and hydrogel-based hemostatic patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodegradable Hemostat Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biodegradable hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodegradable hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable hemostat market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Natural Polymer-Based Hemostats; Synthetic Polymer-Based Hemostats; Composite Hemostats; Cellulose-Based Hemostats; Gelatin-Based Hemostats
• 2) By Formulation: Powdered Hemostats; Granular Hemostats; Liquid Hemostats; Foam Hemostats; Film Or Sheet Hemostats
• 3) By Application: Surgical Procedures; Trauma Procedures; Dental Procedures; Laparoscopic Procedures; Other Applications
• 4) By Distribution Channel: Direct Sales; Distributors; E-Commerce Platforms; Pharmaceutical Retailers; Healthcare Supply Companies
• 5) By End-User: Hospitals; Ambulatory Surgical Centers; Clinics; Research Laboratories; Other End Users
• Subsegments:
• 1) By Natural Polymer-Based Hemostats: Collagen-Based; Chitosan-Based; Alginate-Based; Fibrin-Based; Dextran-Based
• 2) By Synthetic Polymer-Based Hemostats: Polyethylene Glycol (PEG)-Based; Polyurethane-Based; Polylactic Acid (PLA)-Based; Polyglycolic Acid (PGA)-Based; Polycaprolactone (PCL)-Based
• 3) By Composite Hemostats: Natural-Synthetic Polymer Blends; Polymer-Cellulose Composites; Polymer-Gelatin Composites; Multi-Layer Composites; Nano-Composite Hemostats
• 4) By Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC); Microcrystalline Cellulose (MCC); Carboxymethyl Cellulose (CMC); Nanocellulose-Based; Hydroxypropyl Cellulose (HPC)
• 5) By Gelatin-Based Hemostats: Porcine Gelatin-Based; Bovine Gelatin-Based; Fish Gelatin-Based; Cross-Linked Gelatin; Modified Gelatin Formulations
• Companies Mentioned: Johnson And Johnson Services Inc; Medtronic Plc; Stryker Corporation; Baxter International Inc; Meril Life Sciences Pvt Ltd; Samyang Holdings Corp; Molnlycke Health Care AB; GELITA Medical GmbH; B Braun Melsungen AG; Tricol Biomedical Inc; Hemostasis LLC; Cura Medical; RevMedx Inc; Speed Care Mineral GmbH; Regenity; C R Bard Inc; Integra LifeSciences Corporation; Advanced Medical Solutions Group plc; Anika Therapeutics Inc; Marine Polymer Technologies Inc; Axio Biosolutions Pvt Ltd; Biom Up Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Biodegradable Hemostat Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Biodegradable Hemostat Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Biodegradable Hemostat Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Biodegradable Hemostat Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Absorbable Hemostatic Products
  • 4.2.2 Growing Preference For Biocompatible And Bioabsorbable Materials
  • 4.2.3 Increasing Use In Minimally Invasive And Laparoscopic Surgeries
  • 4.2.4 Expansion Of Advanced Hemostats In Trauma And Emergency Care
  • 4.2.5 Higher Demand For Ready-To-Use And Easy-To-Apply Hemostats

5. Biodegradable Hemostat Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Surgical Centers
• 5.3 Clinics
• 5.4 Trauma And Emergency Care Centers
• 5.5 Research Laboratories

6. Biodegradable Hemostat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biodegradable Hemostat Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Biodegradable Hemostat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Biodegradable Hemostat Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Biodegradable Hemostat Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Biodegradable Hemostat Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biodegradable Hemostat Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biodegradable Hemostat Market Segmentation

• 9.1. Global Biodegradable Hemostat Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Natural Polymer-Based Hemostats, Synthetic Polymer-Based Hemostats, Composite Hemostats, Cellulose-Based Hemostats, Gelatin-Based Hemostats
• 9.2. Global Biodegradable Hemostat Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Powdered Hemostats, Granular Hemostats, Liquid Hemostats, Foam Hemostats, Film Or Sheet Hemostats
• 9.3. Global Biodegradable Hemostat Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Surgical Procedures, Trauma Procedures, Dental Procedures, Laparoscopic Procedures, Other Applications
• 9.4. Global Biodegradable Hemostat Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Direct Sales, Distributors, E-Commerce Platforms, Pharmaceutical Retailers, Healthcare Supply Companies
• 9.5. Global Biodegradable Hemostat Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory Surgical Centers, Clinics, Research Laboratories, Other End Users
• 9.6. Global Biodegradable Hemostat Market, Sub-Segmentation Of Natural Polymer-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Collagen-Based, Chitosan-Based, Alginate-Based, Fibrin-Based, Dextran-Based
• 9.7. Global Biodegradable Hemostat Market, Sub-Segmentation Of Synthetic Polymer-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polyethylene Glycol (PEG)-Based, Polyurethane-Based, Polylactic Acid (PLA)-Based, Polyglycolic Acid (PGA)-Based, Polycaprolactone (PCL)-Based
• 9.8. Global Biodegradable Hemostat Market, Sub-Segmentation Of Composite Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Natural-Synthetic Polymer Blends, Polymer-Cellulose Composites, Polymer-Gelatin Composites, Multi-Layer Composites, Nano-Composite Hemostats
• 9.9. Global Biodegradable Hemostat Market, Sub-Segmentation Of Cellulose-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oxidized Regenerated Cellulose (ORC), Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Nanocellulose-Based, Hydroxypropyl Cellulose (HPC)
• 9.10. Global Biodegradable Hemostat Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Porcine Gelatin-Based, Bovine Gelatin-Based, Fish Gelatin-Based, Cross-Linked Gelatin, Modified Gelatin Formulations

10. Biodegradable Hemostat Market Regional And Country Analysis

• 10.1. Global Biodegradable Hemostat Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Biodegradable Hemostat Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biodegradable Hemostat Market

• 11.1. Asia-Pacific Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biodegradable Hemostat Market

• 12.1. China Biodegradable Hemostat Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biodegradable Hemostat Market

• 13.1. India Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biodegradable Hemostat Market

• 14.1. Japan Biodegradable Hemostat Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biodegradable Hemostat Market

• 15.1. Australia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biodegradable Hemostat Market

• 16.1. Indonesia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biodegradable Hemostat Market

• 17.1. South Korea Biodegradable Hemostat Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biodegradable Hemostat Market

• 18.1. Taiwan Biodegradable Hemostat Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biodegradable Hemostat Market

• 19.1. South East Asia Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biodegradable Hemostat Market

• 20.1. Western Europe Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biodegradable Hemostat Market

• 21.1. UK Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biodegradable Hemostat Market

• 22.1. Germany Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biodegradable Hemostat Market

• 23.1. France Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biodegradable Hemostat Market

• 24.1. Italy Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biodegradable Hemostat Market

• 25.1. Spain Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biodegradable Hemostat Market

• 26.1. Eastern Europe Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biodegradable Hemostat Market

• 27.1. Russia Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biodegradable Hemostat Market

• 28.1. North America Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biodegradable Hemostat Market

• 29.1. USA Biodegradable Hemostat Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biodegradable Hemostat Market

• 30.1. Canada Biodegradable Hemostat Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biodegradable Hemostat Market

• 31.1. South America Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biodegradable Hemostat Market

• 32.1. Brazil Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biodegradable Hemostat Market

• 33.1. Middle East Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biodegradable Hemostat Market

• 34.1. Africa Biodegradable Hemostat Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Biodegradable Hemostat Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biodegradable Hemostat Market Regulatory and Investment Landscape

36. Biodegradable Hemostat Market Competitive Landscape And Company Profiles

• 36.1. Biodegradable Hemostat Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Biodegradable Hemostat Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Biodegradable Hemostat Market Company Profiles
  • 36.3.1. Johnson And Johnson Services Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Baxter International Inc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Meril Life Sciences Pvt Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Biodegradable Hemostat Market Other Major And Innovative Companies

• Samyang Holdings Corp, Molnlycke Health Care AB, GELITA Medical GmbH, B Braun Melsungen AG, Tricol Biomedical Inc, Hemostasis LLC, Cura Medical, RevMedx Inc, Speed Care Mineral GmbH, Regenity, C R Bard Inc, Integra LifeSciences Corporation, Advanced Medical Solutions Group plc, Anika Therapeutics Inc, Marine Polymer Technologies Inc

38. Global Biodegradable Hemostat Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biodegradable Hemostat Market

40. Biodegradable Hemostat Market High Potential Countries, Segments and Strategies

• 40.1 Biodegradable Hemostat Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Biodegradable Hemostat Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Biodegradable Hemostat Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer